These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 110689)
1. Effect of type-specific active immunization on the development and progression of experimental Pseudomonas aeruginosa endocarditis. Archer GL; Johnston JL Infect Immun; 1979 Apr; 24(1):167-73. PubMed ID: 110689 [TBL] [Abstract][Full Text] [Related]
2. Influence of Staphylococcus aureus antibody on experimental endocarditis in rabbits. Greenberg DP; Ward JI; Bayer AS Infect Immun; 1987 Dec; 55(12):3030-4. PubMed ID: 3679543 [TBL] [Abstract][Full Text] [Related]
3. Passive immunization with anti- chimeric protein PilQ/PilA -DSL region IgY does not protect against mortality associated with Pseudomonas aeruginosa sepsis in a rabbit model. Zamani K; Irajian G; Zahedi Bialvaei A; Zahraei Salehi T; Khormali M; Vosough A; Masjedian Jazi F Mol Immunol; 2022 Jan; 141():258-264. PubMed ID: 34896925 [TBL] [Abstract][Full Text] [Related]
4. [Protective effect of Pseudomonas-specific immunoglobulin from the rabbit and of active immunization in experimental Pseudomonas sepsis in mice]. Trautmann M; Brückner O; Hahn H Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Jul; 252(3):370-83. PubMed ID: 6215803 [TBL] [Abstract][Full Text] [Related]
5. Effect of immunization on the genesis of pneumococcal endocarditis in rabbits. Adler SW; Selinger DS; Reed WP Infect Immun; 1981 Oct; 34(1):55-61. PubMed ID: 7298192 [TBL] [Abstract][Full Text] [Related]
6. Experimental endocarditis due to Pseudomonas aeruginosa. I. Description of a model. Archer G; Fekety FR J Infect Dis; 1976 Jul; 134(1):1-7. PubMed ID: 820812 [TBL] [Abstract][Full Text] [Related]
7. Immunization with R mutants of Salmonella minnesota. II. Comparison of the protective effect of immunization with lipid A and the Re mutant. Bruins SC; Stumacher R; Johns MA; McCabe WR Infect Immun; 1977 Jul; 17(1):16-20. PubMed ID: 407161 [TBL] [Abstract][Full Text] [Related]
8. Secretory IgA inhibits Pseudomonas aeruginosa binding to cornea and protects against keratitis. Masinick SA; Montgomery CP; Montgomery PC; Hazlett LD Invest Ophthalmol Vis Sci; 1997 Apr; 38(5):910-8. PubMed ID: 9112987 [TBL] [Abstract][Full Text] [Related]
9. A live-attenuated Pseudomonas aeruginosa vaccine elicits outer membrane protein-specific active and passive protection against corneal infection. Zaidi TS; Priebe GP; Pier GB Infect Immun; 2006 Feb; 74(2):975-83. PubMed ID: 16428743 [TBL] [Abstract][Full Text] [Related]
10. IL-17 is a critical component of vaccine-induced protection against lung infection by lipopolysaccharide-heterologous strains of Pseudomonas aeruginosa. Priebe GP; Walsh RL; Cederroth TA; Kamei A; Coutinho-Sledge YS; Goldberg JB; Pier GB J Immunol; 2008 Oct; 181(7):4965-75. PubMed ID: 18802100 [TBL] [Abstract][Full Text] [Related]
11. Protection against endocarditis due to Staphylococcus epidermidis by immunization with capsular polysaccharide/adhesin. Takeda S; Pier GB; Kojima Y; Tojo M; Muller E; Tosteson T; Goldmann DA Circulation; 1991 Dec; 84(6):2539-46. PubMed ID: 1959203 [TBL] [Abstract][Full Text] [Related]
12. [Evaluation of properties of Pseudomonas aeruginosa recombinant outer membrane protein F (OprF)]. Zlygostev SA; Gataullin AG; Kaloshin AA; Mikhaĭlova NA; Zverev VV Zh Mikrobiol Epidemiol Immunobiol; 2006; (7):43-7. PubMed ID: 17297879 [TBL] [Abstract][Full Text] [Related]
13. Antibodies to capsular polysaccharides are not protective against experimental Staphylococcus aureus endocarditis. Nemeth J; Lee JC Infect Immun; 1995 Feb; 63(2):375-80. PubMed ID: 7821999 [TBL] [Abstract][Full Text] [Related]
14. Pulmonary clearance of Pseudomonas aeruginosa in neutropenic mice. Effects of systemic immunization. Dunn MM; Kamp DW Am Rev Respir Dis; 1987 Jun; 135(6):1294-9. PubMed ID: 3109290 [TBL] [Abstract][Full Text] [Related]
15. Intratracheal immunization with pili protein protects against mortality associated with Pseudomonas aeruginosa pneumonia in mice. Ohama M; Hiramatsu K; Miyajima Y; Kishi K; Nasu M; Kadota J FEMS Immunol Med Microbiol; 2006 Jun; 47(1):107-15. PubMed ID: 16706793 [TBL] [Abstract][Full Text] [Related]
16. Role of nonagglutinating antibody in the protracted immunity of vaccinated mice to Pseudomonas aeruginosa infection. Moody MR; Kessel RW; Young VM; Fiset P Infect Immun; 1978 Sep; 21(3):905-13. PubMed ID: 101467 [TBL] [Abstract][Full Text] [Related]
17. Mucosal and systemic immunizations with killed Pseudomonas aeruginosa protect against acute respiratory infection in rats. Cripps AW; Dunkley ML; Clancy RL Infect Immun; 1994 Apr; 62(4):1427-36. PubMed ID: 8132349 [TBL] [Abstract][Full Text] [Related]
18. Immunization of burn-patients with a Pseudomonas aeruginosa outer membrane protein vaccine elicits antibodies with protective efficacy. Lee NG; Jung SB; Ahn BY; Kim YH; Kim JJ; Kim DK; Kim IS; Yoon SM; Nam SW; Kim HS; Park WJ Vaccine; 2000 Mar; 18(18):1952-61. PubMed ID: 10699346 [TBL] [Abstract][Full Text] [Related]
19. Pathogenic effects of monocytopenia, granulocytopenia and dexamethasone on the course of experimental Pseudomonas aeruginosa endocarditis in rabbits. Bayer AS; Yih J; Chiu CY; Nast CC Chemotherapy; 1989; 35(4):278-88. PubMed ID: 2504546 [TBL] [Abstract][Full Text] [Related]
20. Structural analysis and immunogenicity of Pseudomonas aeruginosa immunotype 2 high molecular weight polysaccharide. Pier GB; Bennett SE J Clin Invest; 1986 Feb; 77(2):491-5. PubMed ID: 3080477 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]